Drugs / Plasma derived FIX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01233440 | Oct 2010 → Jul 2011 | hemophilia B | CSL Behring | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plasma derived FIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01233440 ↗ |
| Known as | pdFIX | “Plasma derived FIX [pdFIX]” NCT01233440 ↗ |
| Modality | Protein / enzyme biologic | “their previous FIX product (plasma-derived or recombinant)” PMID 22859609 ↗ Aug 2012 |